Squarepoint Ops LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$293,000
-43.5%
10,644
-66.2%
0.00%
-66.7%
Q1 2021$519,000
+140.3%
31,472
+168.0%
0.00%
+50.0%
Q4 2020$216,000
-82.5%
11,744
-87.0%
0.00%
-88.2%
Q3 2020$1,232,000
+215.9%
90,553
+316.4%
0.02%
+183.3%
Q2 2020$390,000
+102.1%
21,747
-8.3%
0.01%
+500.0%
Q4 2019$193,000
+50.8%
23,711
+83.6%
0.00%0.0%
Q3 2019$128,00012,9140.00%
Other shareholders
TRANSLATE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders